Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study

Cytokine

Volumn 64, Issue 1, 2013, Pages 90-96

  Michael, B D ^a,b   Elsone, L ^a   Griffiths, M J ^b   Faragher, B ^c   Borrow, R ^d   Solomon, T ^a,b   Jacob, A ^a  

^a THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Eosinophil; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; CHEMOKINE; CYCLOPHOSPHAMIDE; CYTOKINE; EOTAXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOXANTRONE; MYCOPHENOLIC ACID; MYELOPEROXIDASE; PREDNISOLONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELL DIFFERENTIATION; CHEMOTAXIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE FUNCTION; MALE; MEDIATOR RELEASE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUTROPHIL; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; UNITED KINGDOM;

EOSINOPHIL; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUAPORIN 4; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CHEMOKINE CCL11; CHEMOKINE CCL4; CHEMOTAXIS; EOSINOPHILS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; NEUTROPHILS; PEROXIDASE; PILOT PROJECTS; YOUNG ADULT;

EID: 84883554423     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.07.019     Document Type: Article

References (19)

1. Jun-ichi K. Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis. Pathophysiology 2011, 18:69-79.
2. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., et al. Pattern-specific loss of aquaporin-4 immunoreactivitiy distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
3. Ishizu T., Osoegawa M., Mei F.J., Kikuchi H., Tanaka M., Takakura Y., et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005, 128:988-1002.
4. Correale J., Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004, 63:2363-2370.
5. Uzawa A., Mori M., Arai K., Sato Y., Hayakawa S., Masuda S., et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin 6. Mult Scler 2010, 16(12):1443-1452.
6. Griffiths M.J., Ooi M.H., Wong S.C., et al. Examining the host response in enterovirus 71 infection highlights IL-1b, IL-1 receptor antagonist and G-CSF in encephalitis with cardio-respiratory compromise. J Infect Dis 2012, [ahead of print] PMID: 22829643.
7. Wingerchuk D.M., Lennon V.A., Pittock S.J., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
8. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
9. Szodoray P., Alex P., Chappell-Woodward C.M., et al. Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology 2007, 46:417-425.
10. Wang K.C., Lee C.L., Chen S.Y., Chen J.C., Yang C.W., Chen S.J., et al. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. J Interferon Cytokine Res 2013 Feb, 33(2):58-64. 10.1089/jir.2012.0040.
11. Wang H., Wang K., Wang C., Xu F., Zhong X., Qiu W., et al. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation 2013, 20(2):113-118. 10.1159/000345994. Epub 2013 Jan 10.
12. Bugl S., Wirths S., Muller M.R., Radsak M.P., Kopp H.G. Current insights into neutrophil homeostasis. Ann NY Acad Sci 2012, 1266:171-178.
13. Mannon P.J., Hornung R.L., Yang Z., Yi C., Groden C., Friend J., et al. Suppression of inflammation in ulcerative colitis by interferon b1a is accompanied by inhibition of IL-13 production. Gut 2011, 60(4):449-455.
14. Jacob A., Saadoun S., Kitley J., Leite M., Palace J., Schon F., et al. Detrimental role of granulocyte-colony stimulating factor in Neuromyelitis optica: clinical case and histological evidence. Mult Scler 2012, 18(12):1801-1803.
15. Moudgil K.D., Choubey D. Cytokines in Autoimmunity: Role in Induction, Regulation, and Treatment. J Interf Cytok Res 2011, 31(10):695-703.
16. Tanaka M., Matsushita T., Tateishi T., Ochi H., Kawano Y., Mei F.J., et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008, 71:974-981.
17. Minohara M., Matsuoka T., Li W., Osoegawa M., Ishizu T., Ohyagi Y., et al. Up-regulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 2006, 178:156-160.
18. Linhares U.C., Schiavoni P.B., Barros P.O., Kasahara T.M., Teixeira B., Ferreira T.B., et al. The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol 2012, 10.1007/s10875-012-9780-2.
19. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.